Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

MTRR rs1801394 and its interaction with MTHFR rs1801133 in colorectal cancer: a case-control study and meta-analysis.

Haerian MS, Haerian BS, Molanaei S, Kosari F, Sabeti S, Bidari-Zerehpoosh F, Abdolali E.

Pharmacogenomics. 2017 Jul;18(11):1075-1084. doi: 10.2217/pgs-2017-0030. Epub 2017 Jul 10.

PMID:
28691890
2.

The roles of MTRR and MTHFR gene polymorphisms in congenital heart diseases: a meta-analysis.

Xu A, Wang W, Jiang X.

Biosci Rep. 2018 Dec 7;38(6). pii: BSR20181160. doi: 10.1042/BSR20181160. Print 2018 Dec 21.

3.

MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic.

Pardini B, Kumar R, Naccarati A, Prasad RB, Forsti A, Polakova V, Vodickova L, Novotny J, Hemminki K, Vodicka P.

Mutat Res. 2011 Mar 18;721(1):74-80. doi: 10.1016/j.mrgentox.2010.12.008. Epub 2011 Jan 4.

PMID:
21211571
4.

[Association of folate metabolism genes MTRR and MTHFR with complex congenital abnormalities among Chinese population in Shanxi Province, China].

Zhang Q, Bai BL, Liu XZ, Miao CY, Li HL.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Aug;16(8):840-5. Chinese.

5.

Folate-genetics and colorectal neoplasia: what we know and need to know next.

Figueiredo JC, Levine AJ, Crott JW, Baurley J, Haile RW.

Mol Nutr Food Res. 2013 Apr;57(4):607-27. doi: 10.1002/mnfr.201200278. Epub 2013 Feb 8. Review.

PMID:
23401104
6.

The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.

Zhou D, Mei Q, Luo H, Tang B, Yu P.

Int J Biol Sci. 2012;8(6):819-30. doi: 10.7150/ijbs.4462. Epub 2012 Jun 8.

7.

The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.

Lin KM, Yang MD, Tsai CW, Chang WS, Hsiao CL, Jeng LB, Yueh TC, Lee MC, Bau DT.

Anticancer Res. 2018 Apr;38(4):2001-2006.

PMID:
29599316
8.

Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE).

Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G, Haouy S, Chastagner P, Ducassou S, Rialland X, Hémon D, Clavel J.

Cancer Causes Control. 2012 Aug;23(8):1265-77. doi: 10.1007/s10552-012-0004-0. Epub 2012 Jun 16.

PMID:
22706675
9.

Are MTHFR C677T and MTRR A66G Polymorphisms Associated with Overweight/Obesity Risk? From a Case-Control to a Meta-Analysis of 30,327 Subjects.

Fan SJ, Yang BY, Zhi XY, He M, Wang D, Wang YX, Wang YN, Wei J, Zheng QM, Sun GF.

Int J Mol Sci. 2015 May 26;16(6):11849-63. doi: 10.3390/ijms160611849.

10.

Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis.

Xu L, Qin Z, Wang F, Si S, Li L, Lin P, Han X, Cai X, Yang H, Gu Y.

Biosci Rep. 2017 Dec 7;37(6). pii: BSR20170917. doi: 10.1042/BSR20170917. Print 2017 Dec 22.

11.

Evaluation of association studies and meta-analyses of MTHFR gene polymorphisms in colorectal cancer.

Haerian BS, Haerian MS.

Pharmacogenomics. 2015;16(4):413-25. doi: 10.2217/pgs.14.177.

PMID:
25823789
12.

A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.

Wu PP, Tang RN, An L.

J BUON. 2015 May-Jun;20(3):918-22. Review.

13.

Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects.

Nakao H, Wakai K, Ishii N, Kobayashi Y, Ito K, Yoneda M, Mori M, Nojima M, Kimura Y, Endo T, Matsuyama M, Ishii H, Ueno M, Kuruma S, Egawa N, Matsuo K, Hosono S, Ohkawa S, Nakamura K, Tamakoshi A, Takahashi M, Shimada K, Nishiyama T, Kikuchi S, Lin Y.

BMC Gastroenterol. 2016 Jul 29;16(1):83. doi: 10.1186/s12876-016-0503-7.

14.

MTRR polymorphism and the risk for colorectal and breast cancer in Romanian patients--a preliminary study.

Burcoş T, Toma M, Stavarachi M, Cimponeriu D, Apostol P, Popa E, Stăñilescu S, Popa I, Radu I, Serafinceanu C, Panduru N, Beluşică L, Gavrilă L.

Chirurgia (Bucur). 2010 May-Jun;105(3):379-82.

PMID:
20726305
15.

Parental Genetic Variants, MTHFR 677C>T and MTRR 66A>G, Associated Differently with Fetal Congenital Heart Defect.

Guo QN, Wang HD, Tie LZ, Li T, Xiao H, Long JG, Liao SX.

Biomed Res Int. 2017;2017:3043476. doi: 10.1155/2017/3043476. Epub 2017 Jul 3.

16.

Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case-control study in Northern China.

Yang B, Fan S, Zhi X, Wang D, Li Y, Wang Y, Wang Y, Wei J, Zheng Q, Sun G.

Int J Mol Sci. 2014 Nov 25;15(12):21687-702. doi: 10.3390/ijms151221687.

17.

Lack of Association Between MTHFR, MTR, MTRR, and TCN2 Genes and Nonsyndromic CL±P in a Chinese Population: Case-Control Study and Meta-Analysis.

Jiang C, Yin N, Zhao Z, Wu D, Wang Y, Li H, Song T.

Cleft Palate Craniofac J. 2015 Sep;52(5):579-87. doi: 10.1597/14.067. Epub 2014 Aug 8.

PMID:
25105440
18.

MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.

Sheng X, Zhang Y, Zhao E, Lu S, Zheng X, Ge H, Lu W.

Mol Biol Rep. 2012 Oct;39(10):9669-79. doi: 10.1007/s11033-012-1832-4. Epub 2012 Jun 23.

PMID:
22729883
19.

Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review.

Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J.

Am J Epidemiol. 2009 Nov 15;170(10):1207-21. doi: 10.1093/aje/kwp275. Epub 2009 Oct 21. Review.

20.

[Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women].

Liao YP, Bao MS, Liu CQ, Liu H, Zhang D.

Yi Chuan. 2010 May;32(5):461-6. Chinese.

PMID:
20466634

Supplemental Content

Support Center